In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)

被引:6
|
作者
Reddy, Vishwanatha R. A. P. [1 ]
Mwangi, William [1 ]
Sadigh, Yashar [1 ]
Nair, Venugopal [1 ]
机构
[1] Pirbright Inst, Viral Oncogenesis Grp, Pirbright, England
基金
英国生物技术与生命科学研究理事会;
关键词
chPD-1; chPD-L1; monoclonal antibodies; cancer; pathways; T-CELLS; ANTIBODY; EXHAUSTION; EXPRESSION; PATHWAY; BINDING; SAFETY;
D O I
10.3389/fcimb.2019.00436
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the present study, we determined the in vitro characteristics and binding interactions of chicken PD-1 (chPD-1) and PD-L1 (chPD-L1) and developed a panel of specific monoclonal antibodies against the two proteins. ChPD-1 and chPD-L1 sequence identities and similarities were lower compared with those of humans and other mammalian species. Furthermore, in phylogenetic analysis, chPD-1 and chPD-L1 were grouped separately from the mammalian PD-1 and PD-L1 sequences. As in other species, chPD-1 and chPD-L1 sequences showed signal peptide, extracellular domain, a transmembrane domain and intracellular domain. Based on the three dimensional (3D) structural homology, chPD-1, and chPD-L1 were similar to 3D structures of mammalian PD-1 and PD-L1. Further, Ig V domain of chPD-1 and the Ig V and Ig C domains of chPD-L1 were highly conserved with the mammalian counterparts. In vitro binding interaction studies using Superparamagnetic Dynabeads (R) confirmed that recombinant soluble chPD-1/PD-L1 fusion proteins and surface chPD-1/PD-L1 proteins interacted with each other on COS cells. Two monoclonal antibodies specific against chPD-1 and five antibodies against chPD-L1 were developed and their specific binding characteristics confirmed by immunofluorescence staining and Western blotting.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1)
    Wen, Biyan
    Zhao, Lin
    Wang, Yuchu
    Qiu, Chuangnan
    Xu, Zhimin
    Huang, Kunling
    Zhu, He
    Li, Zemin
    Li, Huangjin
    [J]. PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2020, 50 (03): : 252 - 259
  • [2] Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
    Rezende Delgado, Ronan Jacques
    Ramos Pinheiro, Claudia
    Gasparoto, Thais Helena
    Sipert, Carla Renata
    de Moraes, Ivaldo Gomes
    Garcia, Roberto Brandao
    Bramante, Clovis Monteiro
    Bernardineli, Norberti
    Nishiyama, Celso Kenji
    da Silva, Joao Santana
    Torres, Sergio Aparecido
    Garlet, Gustavo Ponnpernnaier
    Campanelli, Ana Paula
    [J]. EUROPEAN ENDODONTIC JOURNAL, 2019, 4 (01): : 3 - 8
  • [3] Programmed death 1 (PD-1) and PD-1 ligand (PD-L1) distribution in triple negative breast cancer (TNBC)
    Baker, T. M.
    Gatalica, Z.
    Goldstein, L. J.
    Obeid, E.
    [J]. CANCER RESEARCH, 2017, 77
  • [4] Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers
    Guan, Jian
    Lim, Khin Sandar
    Mekhail, Tarek
    Chang, Chung-Che
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (06) : 851 - 861
  • [5] Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance
    Wang, Liqing
    Han, Rongxiang
    Hancock, Wayne W.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (10) : 2983 - 2990
  • [6] Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms
    Chen, Chi
    Pandey, Anita
    Kundra, Ajay
    Kodali, Sreenath
    Wong, Ching
    Cheung, Tony W.
    Gotlieb, Vladimir K.
    Joseph, Gardith
    Tribie, Sophia
    Wang, Jen-Chin
    [J]. BLOOD, 2018, 132
  • [7] Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics
    Cassol, Clarissa A.
    Owen, Dwight
    Kendra, Kari
    Braga, Juarez R.
    Frankel, Wendy L.
    Arnold, Christina A.
    [J]. HISTOPATHOLOGY, 2020, 77 (02) : 240 - 249
  • [8] Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1
    Zak, Krzysztof M.
    Kitel, Radoslaw
    Przetocka, Sara
    Golik, Przemyslaw
    Guzik, Katarzyna
    Musielak, Bogdan
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    [J]. STRUCTURE, 2015, 23 (12) : 2341 - 2348
  • [9] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    de Souza Malaspina, Tatiana Salles
    Gasparoto, Thais Helena
    Sales Nogueira Costa, Maria Renata
    de Melo, Edgard Franco, Jr.
    Valerio Ikoma, Maura Rosane
    Damante, Jose Humberto
    Cavassani, Karen Angelica
    Garlet, Gustavo Pompermaier
    da Silva, Joao Santana
    Campanelli, Ana Paula
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) : 965 - 974
  • [10] Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma
    Tatiana Salles de Souza Malaspina
    Thaís Helena Gasparoto
    Maria Renata Sales Nogueira Costa
    Edgard Franco de Melo
    Maura Rosane Valério Ikoma
    José Humberto Damante
    Karen Angélica Cavassani
    Gustavo Pompermaier Garlet
    João Santana da Silva
    Ana Paula Campanelli
    [J]. Cancer Immunology, Immunotherapy, 2011, 60 : 965 - 974